Pluri Inc. (PLUR)

↓ Download CSV

CIK 0001158780 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Jun 30

In fiscal 2025, Pluri Inc. reported revenue of $1.34M, up 309.8% from the prior year. The company ran a net loss, with a net margin of -1690.3% and a gross margin of 49.0%.

Key ratios (FY2025)

49.0%
Gross margin
-1659.9%
Operating margin
-1690.3%
Net margin
+309.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.34M$326.0K$287.0K$234.0K$23.0K$54.0K$50.0K$2.85M
Cost of Revenue$682.0K$4.0K$9.0K$2.0K$2.0K$100.0K
Gross Profit$654.0K$322.0K$278.0K$234.0K$23.0K$52.0K$48.0K$2.75M
Operating Income-$22.18M-$22.16M-$27.25M-$41.59M-$50.62M-$29.48M-$35.53M-$33.73M-$28.02M-$23.32M
Net Income-$22.58M-$20.89M-$28.32M-$41.24M-$49.87M-$29.15M-$35.31M-$26.13M-$27.81M-$23.25M
EPS (Diluted)$-3.56$-3.99$-6.24$-1.28$-1.77
Total Assets$38.68M$39.53M$50.80M$68.06M$93.54M$65.53M$31.31M$38.96M$37.53M$45.94M
Shareholders' Equity-$6.84M$96.0K$13.36M$30.04M$57.15M$56.10M$21.82M$28.51M$30.25M$38.16M
Cash & Equivalents$5.89M$6.78M$5.36M$9.77M$31.24M$8.27M$4.11M$8.82M$4.71M$6.22M
Operating Cash Flow-$18.21M-$18.02M-$22.86M-$36.50M-$30.91M-$26.37M-$29.45M-$21.38M-$21.61M-$18.52M
Capital Expenditures$1.62M$323.0K$262.0K$280.0K$373.0K$270.0K$239.0K$342.0K$378.0K$1.75M
Shares Outstanding7.89M5.41M5.16M32.51M31.96M25.49M15.08M11.36M96.94M80.27M